Health TrialsbyHealthPanel

Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students

ConditionTeenagers
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age14-14
SponsorHopital Foch

About this trial

This is a prospective pragmatic study to assess the impact of a HPV vaccination talk in secondary school on actual vaccine dispensing in test communes compared with control communes. The talk consist on a briefing on the importance of vaccination.

This is a controlled study, since two communes will benefit from the HPV vaccination talk, while the other two will serve as controls without set up of the HPV vaccination talk. The set up of this presentation will be open-label.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

3rd grade students enrolled in public secondary schools in Suresnes and Rueil-Malmaison.

Disqualifiers

Students absent on the day of the talk.

Students unwilling/unable to complete questionnaire.

Trial population

3rd grade students enrolled in public secondary schools in Suresnes and Rueil-Malmaison.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • A short talk about the importance of HPV vaccination

    Behavioral

    Investigator plan to set up a short talk to 3rd grade classes in addition to the usual sexual health training. The issue of HPV vaccination will be systematically addressed for 10 minutes to encourage catch-up vaccination. The usual training include different themes such us : definition of sexual health, anatomy, sexually transmitted infections contraception/condoms, menstrual cycles, voluntary interruption of pregnancy, consent, sexual abuse/violence/harassment, pornography, anti-discrimination.... A 45-minute talk will include 2 or 3 topics from the above list. A ten minutes of talk will be added to the usual training to explain the HPV vaccination (a topic not usually addressed in sexual health training), covering the following elements: definition of HPV infection

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Impact Assessement of a sexual health talk with middle school students in 3rd grade on the dispensation of HPV vaccines among young people born in 2010.

The aim of this study is to evaluate the impact of a sexual health talk with middle school students in 3rd grade on the dispensation of HPV vaccines among young people born in 2010. The main evaluation criterion for this study is the number of monthly HPV vaccine dispensations among young people born between 01/01/2010 and 31/12/2010. These data will be communicated by the OSPHARM cooperative or by pharmacies, over the 12 months preceding the talk and the 6 months following, in order to be able to assess the impact of the latter on dispensations.

Time frame
12 months preceding the talk and the 6 months following the talk

Secondary outcomes

1

1rst Secondary outcoume

Evaluate the implementation of sexuality education sessions as part of middle school educational programs.

Time frame
8 weeks
2

2nd Secondary outcoume

Evaluate the knowledge of Suresnes and Rueil-Malmaison 3rd grade students about HPV infection and HPV vaccination before and after the talk. This outcome will be evaluated through questionnaire

Time frame
8 weeks
3

3rd secondary outcoume

Evaluate middle-school students; satisfaction with the HPV vaccination information talk. This outcome will be evaluated through questionnaire

Time frame
8 weeks
4

4 th secondary outcoume

Evaluate adherence to the sexual health talk by Suresnes and Rueil-Malmaison middle schools. This outcome will be assessed through the mesearement of the rate of completed questionnaires

Time frame
8 weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hopital Foch

Lead sponsor

Agence Regionale de Sante d'Ile de France

Collaborator

Ospharm coopérative

Collaborator

French Interregional Group of Clinical Research and Innovation

Collaborator

Communauté professionnelle territoriale de santé

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: